DF
BSX icon

DecisionPoint Financial’s Boston Scientific BSX Stock Holding History

DecisionPoint Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216 Sell
5
-61
-92% -$3.31K ﹤0.01% 923
2026
Q1 		$4.14K Hold
66
– – ﹤0.01% 235
2025
Q4 		$6.29K Hold
66
– – ﹤0.01% 227
2025
Q3 		$6.33K Hold
66
– – ﹤0.01% 160
2025
Q2 		$6.92K Buy
+66
New +$6.68K ﹤0.01% 162

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DecisionPoint Financial's BSX Position: Q2 2026 in Review

DecisionPoint Financial reduced its Boston Scientific (BSX) stake by 92% in Q2 2026, selling an estimated $3.31K and leaving 5 shares worth $216. The position accounts for ﹤0.01% of the portfolio, ranked #923.

DecisionPoint Financial first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.92K in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • DecisionPoint Financial held 5 shares of Boston Scientific worth $216 as of Q2 2026.
  • DecisionPoint Financial sold 61 Boston Scientific shares in Q2 2026, an estimated $3.31K.
  • Boston Scientific made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #923 holding.
  • DecisionPoint Financial first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • DecisionPoint Financial's Boston Scientific position peaked at $6.92K in Q2 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.